Core Viewpoint - The company provides customized research and production services required for drug development from preclinical to clinical trials and market launch, with specific service products being confidential due to commercial agreements [1] Group 1 - The company's revenue from direct exports to the United States has accounted for less than 5% in the past two years, indicating limited impact from current tariff policies [1]